In Vitro Fertilization (IVF) Market Size Will Reach $1036.7

NEW YORK, USA, Sep 17, 2022 (GLOBE NEWSWIRE) — Facts and Factors has released a new research report titled “In Vitro Fertilization (IVF) Market By Type (Conventional IVF, IVF With ICSI, IVF With Donar Eggs, Others), By Cycle (Fresh IVF Cycles Without Donor, Frozen IVF Cycles Without Donor, IVF Cycles With frozen donor, fresh donor IVF cycle), by product (equipment, sperm analysis systems, imaging systems, egg aspiration pumps, micromanipulator systems, incubators, gas analyzers, laser systems, cryosystems, sperm separation devices, IVF cabinets, anti-vibration tables, control systems, other equipment, reagents and media, cryopreservation media, embryo culture media, egg processing media, sperm processing media, accessories) , by End User (Fertility Clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes) and Region – Global and Regional Industry Overview, Market Insights, Comprehensive Analysis, Historical Data and t forecasts 2022-2028 » in its research database.

The Global In Vitro Fertilization (IVF) Market was worth around USD 628.50 million in 2021 and is expected to grow to around USD 1,036.7 million by 2028 growing at a compound annual growth rate (CAGR) of around 8.7% over the forecast period.

The report analyzes drivers, restraints/challenges for the In Vitro Fertilization (IVF) market and their effect on the demands during the projection period. Additionally, the report explores emerging trends and opportunities in the in vitro fertilization (IVF) market.

IVF Industry Synopsis:

In Vitro Fertilization (IVF) brings reproductive technology to real life and helps couples conceive children who have complications to do so the natural way. The increase in sedentary lifestyles and inappropriate habits has led to an increase in impotence and other fertility problems across the world and therefore propelled the demand for in vitro fertilization (IVF), which are clinics for fertility treatments capable of treating reproductive problems.

Rising popularity of in vitro fertilization (IVF), growing availability of in vitro fertilization (IVF) procedures and increasing healthcare expenditures are expected to be significant trends that will drive the growth of the in vitro fertilization (IVF) market ) over the forecast period. However, the high costs associated with these procedures will have a dampening effect on the growth of the in vitro fertilization (IVF) market.

Click here to access Free Sample Report of Global In Vitro Fertilization (IVF) Market @ https://www.fnfresearch.com/sample/in-vitro-fertilization-market

Industry growth factors

Growth in median age of first-time mothers

The increasing evolution of the human population has raised the median age of first-time mothers to a considerably high number due to the growing number of women preferring late marriages and choosing careers over family planning, contrary to past trends. . The effective use of contraceptives has also played a crucial role in shaping the trend of the median age of first-time mothers, which is expected to significantly boost the growth of the in vitro fertilization (IVF) market during the the forecast period.

Constraints

High Costs of In Vitro Fertilization (IVF) Procedure

In Vitro Fertilization (IVF) procedures are known to be costly across the globe and this is the major factor that will hamper the potential of the In Vitro Fertilization (IVF) market during the forecast period. Lack of insurance coverage aggravates this situation in countries where healthcare is costly and irregularities in reimbursements for these procedures also have a detrimental effect on the overall growth of the in vitro fertilization (IVF) market.

Purchase a copy of the report directly with [email protected] https://www.fnfresearch.com/buynow/su/in-vitro-fertilization-market

Segmental Knowledge

The global in vitro fertilization (IVF) market is segregated based on type, cycle, product, end-use, and region.

By end user, the in vitro fertilization (IVF) market is segmented into fertility clinics, hospitals and surgical centers, cryobanks and research institutes. The fertility clinics segment will have a good outlook on the forecast as governments around the world focus on establishing these clinics to ensure public health and fertility awareness to promote the birth rate.

The global in vitro fertilization (IVF) market is segmented as follows:

By type

  • Conventional IVF
  • IVF with ICSI
  • IVF with Donar Eggs
  • Others

Per round

  • Fresh IVF cycles without donor
  • Frozen Donorless IVF Cycles
  • IVF cycles with frozen donor
  • IVF cycle with fresh donor

By product

  • Equipment
  • Sperm analysis systems
  • Imaging systems
  • Egg Suction Pumps
  • Micromanipulator systems
  • Incubators
  • Gas analyzers
  • Laser systems
  • Cryosystems
  • Sperm separation devices
  • IVF practices
  • Anti-vibration tables
  • Witness systems
  • Other equipment
  • Reagents and Media
  • Cryopreservation media
  • Embryo culture media
  • Egg Processing Media
  • Sperm Processing Media
  • Accessories

Per end user

  • Fertility clinics
  • Hospitals and surgical centers
  • Cryobanks
  • Research institutes

Browse all “In Vitro Fertilization (IVF) Market – Global and Regional Industry Overview, Market Insights, Comprehensive Analysis, Historical Data and Forecast 2022-2028” Report to https://www.fnfresearch.com/in-vitro-fertilization-market

Competitive landscape

Some of the major competitors dominating the global in vitro fertilization (IVF) market include-

The Cooper Companies Inc. (USA), Cook Group (USA), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (USA), Esco Micro Pte. ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (USA), The Baker Company, Inc. (USA), Kitazato Corporation (Japan), Rocket Medical plc (UK ), Hamilton Thorne Ltd. (USA), ZEISS Group (Germany), FERTIPRO NV (Belgium) and Gynotec BV (Netherlands), among others.

Key insights from primary research:

  • According to the analysis, the in vitro fertilization (IVF) market is expected to grow at a CAGR of approximately 8.7% during the period 2022-2028.
  • In terms of revenue, the in vitro fertilization (IVF) market size was valued at around US$628.50 million in 2021 and is projected to reach US$1,036.7 million by 2028.
  • The fertility clinics segment is expected to have a favorable outlook during the projected period.
  • The non-donor fresh segment is expected to account for a major market share and is expected to be a dominant segment throughout the forecast period.
  • In the Asia-Pacific region, the in vitro fertilization (IVF) market is expected to witness a dominant outlook during the projected period.

Request for customization on this report as per your requirement – https://www.fnfresearch.com/customization/in-vitro-fertilization-market

Regional outlook

The Asia-Pacific region will be the most lucrative market for the in vitro fertilization (IVF) industry during the forecast and this trend is expected to be driven by multiple factors. Growing availability and popularity of in vitro fertilization (IVF) procedures and growing preference of couples to adopt such procedures will be the key trends propelling the growth of the in vitro fertilization (IVF) market in this region during the the forecast period. India and China are expected to be at the forefront of the growth curve in this region until 2028. Increase in medical tourism, increase in the number of in vitro fertilization (IVF) centers, growing focus on fertility , increasing adoption of reproductive technologies and increasing healthcare expenditures are expected to be other significant trends influencing the growth of the in vitro fertilization (IVF) market during the forecast period.

By region

  • North America
    • WE
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • The rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • The Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East and Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

RECENT DEVELOPMENTS

In 2021 – CooperSurgical and Virtus Health announced the launch of a new partnership to strengthen their fertility technology and increase access for infertile couples around the world.

Report scope

Report attribute Details
Market size (2021) $628.50 million
Future Market Size (2028) $1,036.7 million
CAGR growth rate (%) 8.7% CAGR
base year 2021
Forecast period 2022-2028
Important Suppliers The Cooper Companies Inc. (USA), Cook Group (USA), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (USA), Esco Micro Pte. ltd. (Singapore), Genea Limited (Australia), IVFtechApS (Denmark), FUJIFILM Irvine Scientific (USA), The Baker Company, Inc. (USA), Kitazato Corporation (Japan), Rocket Medical plc (UK) , Hamilton Thorne Ltd (USA), ZEISS Group (Germany), FERTIPRO NV (Belgium) and Gynotec BV (Netherlands), among others
major segment By type, cycle, product, end user and region
Key regions North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Browse other related Facts & Factors research reports:

Global Protein Expression Market The share is likely to grow at a CAGR of 12.70% by 2028: https://www.fnfresearch.com/protein-expression-market

Global Donor Egg IVF Services Market The share is likely to grow at a CAGR of 24.10% by 2028: https://www.fnfresearch.com/donor-egg-ivf-services-market

Global Telehealth Market for Women’s Reproductive and Sexual Health The share is likely to grow at a CAGR of 16.20% by 2028: https://www.fnfresearch.com/telehealth-for-womens-reproductive-and-sexual-health-market

Global Medical Transportation Services Market is likely to grow at a CAGR of 4.50% by 2028: https://www.fnfresearch.com/medical-transport-services-market

Global neuroscience market is likely to grow at a CAGR of 3.50% by 2028: https://www.fnfresearch.com/neuroscience-market

Global clinical decision support system market share is likely to grow at a CAGR of approximately 11.9% by 2028: https://www.fnfresearch.com/clinical-decision-support-system-market

About facts and factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups and companies around the world to measure and understand changing international and regional business environments.

Contact us:

Facts and factors

UNITED STATES: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999

E-mail: [email protected] | The Web: https://www.fnfresearch.com

Follow us on – LinkedIn | Twitter | Facebook

About Arla Lacy

Check Also

Wait and watch in the private secondary market amid pressure for discounts

Everyone loves a bargain, especially when it comes to a buyer’s market. The private secondary …